Immunome Announces U.S. FDA Acceptance of New Drug Application for Varegacestat for the Treatment of Adults with Desmoid Tumors

NDA FilingVaregacestatPositive

AI Analysis

Summary

Immunome announced that the U.S. FDA has accepted the New Drug Application for varegacestat for treating adults with desmoid tumors. This regulatory milestone represents progress toward potential market approval.

Outcome Details

FDA acceptance of New Drug Application

Importance:6/10

Sentiment:

0.70

FDANDAOncologyRegulatoryDesmoid tumors

Related Companies

$IMNM

Read the original article

Published by yahoo_finance on July 8, 2026 11:30 AM

Read Original